Editors’ Picks, October 2026: Surgical De-escalation, New CAR T-cell Approaches, and More
The October 2026 Editors’ Picks from AACR journals include findings on multiple primary cancers in World Trade Center responders,...
Tag: head and neck cancer
The October 2026 Editors’ Picks from AACR journals include findings on multiple primary cancers in World Trade Center responders,...
Salivary gland cancer is rare, and there are no standard treatments for advanced-stage disease. Recent research supports the use...
In April 2026, AACR's journals editors highlighted studies on cancer survivors taking GLP-1 agonists, an immunotherapy-boosting bacteria, and more.
Injecting immunotherapy directly into precancerous oral lesions may be an effective way to prevent progression to cancer without surgery.
In February, the editors of AACR's journals highlighted studies on the FDA’s accelerated approval pathway, how metabolism impacts prostate...
The countdown to the new year is nearly upon us, but no need to count down to the last...
In November, the AACR’s journal editors highlighted studies on sucralose limiting immunotherapy, benefits of caloric restriction, and more.
New research is redefining the role of surgery, revealing approaches to help cancer patients preserve their organs, function, and...
For August 2025, the editors of AACR's journals highlighted studies on liquid biopsy for brain cancer, new treatment strategies...
In the second quarter of 2025, the FDA issued 13 new oncology approvals, including options for rare cancers, head...